ATER

Aterian is a shrinking, unprofitable Amazon-dependent consumer-products roll-up whose revenue has collapsed from $248M (FY2021) to $69.0M (FY2025) — a -30.4% decline in the most recent year alone and roughly -72% cumulatively. This is not a temporary dip; it is a four-year, uninterrupted secular contraction. Losses persist ($-19.0M net, a -27.5% net margin) and actually widened 60% YoY even as the top line shrank, so the business is not converging toward profitability — the operating line remains deeply negative at -26.1%. The 56.8% gross margin looks healthy, but the MD&A explains why it doesn't translate to profit: 2025 China tariffs pushed up COGS, and the company's response — 'selective price increases' — 'contributed to a decline in unit volumes as consumer demand responded to the higher retail prices.' That is a demand-destroying doom loop: raise price to protect margin, lose the volume that fills a fixed-cost fulfillment and warehouse base.

The balance sheet is where 'avoid' becomes non-negotiable. Cash fell 73% to just $4.86M while operating cash flow swung to -$10.9M (from roughly break-even) — the company burned more than twice its remaining cash in a single year. At that pace runway is measured in months, and management has only two levers: raise capital (shares already up 23.7% YoY, diluting a 10.8M-share base into a $13.6M market cap) or shrink further. Stockholders' equity dropped 49% to $15.2M and total assets fell 40% to $29.6M — the enterprise is liquidating value, not compounding it. A -124.8% ROE and a -$731M accumulated deficit confirm this business has never created shareholder value at scale.